{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"}],"units":"Participants"}],"description":"Subjects who received at least one dose of mifepristone were included in the safety analysis.","groups":[{"description":"mifepristone at doses from 300 mg/day up to 1200 mg/day daily","id":"OG000","title":"Open-label"}],"paramType":"NUMBER","populationDescription":"Subjects who received one dose of study drug were included in the safety and ITT analyses.","reportingStatus":"POSTED","timeFrame":"Up to three years.","title":"Number of Participants With Adverse Events","type":"PRIMARY","unitOfMeasure":"participants"}